Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors

Mahesh Karande, President and Chief Executive Officer of Omega Therapeutics added, "I am delighted to welcome Richard to the team. Richard is an industry veteran whose wealth of experience and knowledge in corporate finance, business development and strategic licensing will be invaluable as we continue to capitalize on the vast potential of the OMEGA platform and advance our pipeline of novel epigenomic controllers." Omega Therapeutics is a clinical-stage biotechnology company pioneering the development of ...